Struggling with Endometriosis and Infertility? Your Genes May Be the Answer.

MTHFR is your cell’s methylation workhorse. It converts folate into methylfolate, the active form your cells need to build and repair DNA, make neurotransmitters, and manage cellular stress. During pregnancy, this gene becomes even more critical. Your eggs need proper methylation patterns to develop correctly, and your embryo needs methylation to close its neural tube and develop organs.

Here’s the problem: the C677T variant, which roughly 40% of people with European ancestry carry in at least one copy, reduces MTHFR enzyme activity by 35 to 70%. This means your cells are converting folate into usable methylfolate at a fraction of the rate they should be. You can eat a perfect diet rich in folate and still be functionally depleted at the cellular level, which directly impairs egg development and embryo viability.

If you have a MTHFR variant, your eggs may struggle to divide correctly. Your embryos may develop more slowly or with chromosomal abnormalities. Your miscarriage risk climbs. Your homocysteine levels rise (a marker of poor methylation), which also damages egg and sperm DNA. No amount of willpower fixes this; your cells need the right substrate.

COMT is your estrogen-clearing enzyme. It breaks down estrogen so your body can excrete it. When COMT works well, estrogen levels stay in a healthy range. When it doesn’t, estrogen accumulates.

The Val158Met variant affects roughly 25% of people with European ancestry who are homozygous for the slow version. If you carry the slow variant, your body recycles and clears estrogen slowly, causing it to accumulate to higher-than-normal levels. Elevated estrogen is one of the primary drivers of endometriosis. It increases inflammation, thickens the endometrial lining, and feeds the growth of endometrial tissue outside the uterus.

If you have slow COMT, you may notice your endometriosis symptoms worsen at particular points in your cycle when estrogen peaks. You might have severe period pain, heavy bleeding, or worse bloating and fatigue. IVF stimulation, which floods your system with exogenous estrogen, can be particularly brutal because your body can’t clear it efficiently. Your implantation rates may suffer because high estrogen disrupts the delicate endometrial balance needed for pregnancy.

ESR1 encodes the estrogen receptor, the lock that estrogen fits into on your cells. How sensitive your receptors are directly determines how your endometrium (the lining of your uterus) responds to estrogen and progesterone signaling.

The PvuII and XbaI variants in ESR1 affect roughly 40% of the population and alter receptor sensitivity and gene expression. Depending on which variant you carry, your endometrium may be either overly sensitive or under-responsive to the hormonal signals needed for implantation. This can impair endometrial receptivity, which is the window during which an embryo can successfully implant.

If you have an ESR1 variant that reduces sensitivity, your endometrium may not thicken properly, or it may not express the adhesion molecules needed for an embryo to stick. Implantation may fail even if your eggs are high quality and your embryos look perfect. If you have a variant that increases sensitivity, you may develop thicker endometrium and higher endometriosis risk. Either way, your responsiveness to standard hormone replacement protocols may be weaker than expected, which means your doctor keeps increasing doses when the real problem is genetic sensitivity, not hormone level.

FSHR is the receptor on your ovarian cells that catches FSH (follicle-stimulating hormone) signaling. When FSH binds to the FSHR receptor, it tells your ovaries to wake up and grow follicles. How efficiently this conversation happens depends on your FSHR genetics.

The N680S variant (rs6166), where S stands for serine, is present in roughly 10 to 15% of the population. People who carry the S/S genotype have significantly weaker response to FSH stimulation. Your ovarian cells essentially have a lower-sensitivity antenna for FSH, which means you need higher doses of fertility medication to generate the same follicle response that someone with the more common N680 variant achieves naturally.

If you have the S/S variant, you’ve probably noticed this in IVF cycles. You get high FSH doses, your follicles grow more slowly, you need more days of stimulation, your retrieve yields fewer eggs, or your cycle gets cancelled because the response is too poor. It’s not that your ovaries are broken; it’s that they’re genetically wired to need stronger signaling. You may also have lower baseline ovarian reserve (AMH). This variant predicts IVF response more accurately than standard fertility testing does.

VDR is the receptor that lets your cells absorb and use vitamin D. Vitamin D isn’t just a bone nutrient; it’s a master regulator of immune function, inflammation, and reproductive hormones. Your uterus, ovaries, and placenta all have VDR receptors. When this system works well, vitamin D helps regulate immunity (critical for preventing endometriosis and miscarriage), supports progesterone signaling, and improves implantation rates.

The BsmI, ApaI, and TaqI polymorphisms in VDR are common and affect roughly 40 to 50% of the population. Certain VDR variants reduce the efficiency of vitamin D signaling, meaning you absorb and utilize vitamin D poorly even if your blood levels look adequate. This is particularly important for reproductive health because vitamin D deficiency amplifies endometriosis risk, reduces ovarian reserve, impairs implantation, and increases miscarriage.

If you have a VDR variant, your standard blood vitamin D level (say, 30 ng/mL) may look normal on paper but may not be high enough for your cells to use it properly. You may have worse endometriosis despite normal vitamin D labs. Your implantation window may be narrower. Your immune system may be more reactive, driving chronic inflammation. This is a common reason why people supplement with standard doses of vitamin D and see no improvement in their fertility.

FMR1 stands for Fragile X Mental Retardation 1, and while the name sounds alarming, most women with FMR1 premutations have no intellectual disability. What they do have is a much higher risk of premature ovarian insufficiency, or POI, which means their ovaries decline in function earlier than expected.

FMR1 premutations are rare overall, but important to catch. A premutation means you have 55 to 200 CGG repeats in this gene (normal is 5 to 44 repeats). Roughly 1 in 250 females carries a premutation. Women with FMR1 premutations have dramatically elevated FSH levels in their 30s and 40s, declining egg reserve, and sometimes complete ovarian failure before age 40. This is one of the few single-gene findings that directly predicts reproductive aging.

If you have a premutation and you’re struggling with infertility or declining AMH in your 30s or 40s, this is critical information. Your ovarian decline is not a reflection of your health habits or your stress levels. It’s a genetic clock that’s running faster than average. Your eggs are declining faster than expected for your age, which changes your fertility timeline and your decisions about treatment urgency and egg freezing.